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Abstract
Lymphocyte function-associated antigen 1 (LFA-1), a member of b2-integrin family, exerts multiple roles in host T cell
immunity and has been identified as a useful drug-development target for inflammatory and autoimmune diseases.
Applying the findings that primary resting T cells absorb nanometric membrane vesicles derived from antigen presenting
cells (APC) via dual receptor/ligand interactions of T cell receptor (TCR) with cognate peptide-major histocompatibility
complex (MHC) complex (pMHC) and LFA-1 with its ligand, intercellular adhesion molecule-1 (ICAM-1), and that signaling
cascades triggered by TCR/pMHC interaction take a part in the vesicle-absorption, we established a cell-based high
throughput assay for systematic investigation, via isolation of small molecules modulating the level of vesicle-absorption, of
molecular mechanisms underlying the T cell absorption of APC-derived vesicles, i.e., structural basis of TCR/pMHC and LFA-
1/ICAM-1 interactions and TCR-mediated LFA-1 activation. As primary T cells along with physiological ligands expressed in
biological membrane are used and also individual cells in assay samples are analyzed by flow cytometry, results obtained
using the assay system hold superior physiological and therapeutic relevance as well as statistical precision.
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Introduction
Lymphocyte function-associated antigen 1 (LFA-1), an integrin
composed of aL (CD11a) and b2 (CD18) subunits, plays multiple
roles in T cell immunity [1]. It plays a pivotal role in T cell
activation by generating costimulatory signals and promoting
formation of immunological synapse (IS) at the junction of T cell-
antigen presenting cell (APC) contact. It also plays an important
role in migration of effector T cells to the sites of infection and
inflammation by assisting transmigration of those T cells across the
vasculature. It is also involved in execution of effector T cell
functions by directing guided delivery of effector molecules to
specific target cells [2]. In addition, LFA-1 is implicated in various
immunologic diseases such as chronic inflammation and autoim-
mune diseases and has been identified as a target for development
of drugs against those diseases [3,4].
As with other integrins, the functional activity of LFA-1 is
controlled by a form of intracellular signaling, termed ‘inside-out’
signaling [5,6]. When the ‘inside-out’ signal is induced by
interaction of specific receptors with their ligands, e.g., interaction
of T cell receptor (TCR) with cognate peptide/MHC complexes
(pMHCs), both affinity and avidity of LFA-1 for its ligand,
intercellular adhesion molecule-1 (ICAM-1), are enhanced by its
conformational change and spatial rearrangement.
Exosomes are nanometric membrane vesicles formed inside
cells and released into the extracellular space [7]. Previously, we
reported that purified CD8
+ 2C TCR transgenic (Tg) T cells
absorbed exosome-like membrane vesicles (eMVs) purified from
culture supernatants of artificial APCs, namely Drosophila (Dros)
cells expressing various mouse immuno-molecules required for
APC function, and cultured dendritic cell (DC) line [8,9,10]. The
eMV-absorption by 2C T cells was found to be mediated by
specific dual receptor/ligand interactions of 2C TCR with a
cognate pMHC (L
d/QL9 or L
d/p2Ca) plus LFA-1 with ICAM-1.
Further, in this study, we reveal that the vesicle-absorption also
involves intracellular signaling cascades initiated by TCR
triggering and required for LFA-1 activation.
Chemical genetics, a research paradigm for using small
chemical compounds to modify protein function(s) to alter
phenotype(s) of cells or entire organisms, is emerging as a powerful
tool not only for uncovering molecular mechanisms underlying
important biological phenomena but also for exploring new
therapeutics [11,12]. High-throughput screening (HTS) is a key
element of chemical genetic approaches and thus developing HTS
platforms with an innovative concept, simplicity and statistical
precision is pivotal for successful chemical genetic studies. Here,
we introduce a novel high throughput assay for a systematic
investigation of molecular mechanisms controlling TCR-mediated
LFA-1 activation. Given that ex vivo purified primary T cells
along with physiological ligands expressed in biological mem-
branes are used and that individual cells in assay samples are
interrogated by flow cytometry, this HTS system features superior
physiological and therapeutic relevance, high sensitivity and
statistical precision.
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e6044Results
Preparation of plasma membrane-derived microvesicles
The amount of eMVs collected from culture supernatants is
limited. To improve the yield of microvesicles expressing immuno-
molecules of interest, we prepared vesicles from the purified
plasma membrane fraction of Dros APCs.
EM pictures showed that sizes of plasma membrane-derived
vesicles (pMVs) prepared from Dros APCs expressing L
d plus B7-1
and ICAM-1 (L
dB7-1ICAM-1 Dros APCs) were relatively uniform
(approximately 200–300 nm in diameter) (Supplementary Figure
S1A). Accordingly, we were able to estimate the average number
of each mouse immuno-molecule expressed in the pMVs
(Supplementary Figure S1B and C).
We used pMVs expressing L
d plus B7-1 and ICAM-1 (L
dB7-
1ICAM-1 pMVs) for the following reasons. Firstly, lack of B7-1
expression in resting T cells and high level expression of B7-1 in
the pMVs allow us to employ B7-1 mAb staining of T cells as a
readout to measure the extent of pMV-absorption by T cells with
low background and high sensitivity (Figure 1A and Supplemen-
tary Figure S2A). Secondly, using 2C T cells deficient in CD28 or
LFA-1 expression and mAbs blocking interactions of those
receptors with their ligands, it is feasible to probe the contributing
roles of TCR/pMHC, CD28/B7-1 and LFA-1/ICAM-1 interac-
tions in the pMV-absorption.
2C T cell absorption of L
dB7-1ICAM-1 Dros pMVs
As for absorption of Dros eMVs [8], 2C T cells absorbed Dros
pMVs only when the latter were loaded with an agonistic peptide
(QL9 or p2Ca) [13] (Figure 1A and Supplementary Figure S2A).
LFA-1/ICAM-1 interaction played a critical role in the pMV-
absorption. Thus, wild type and CD28
2/2 2C T cells treated with
anti-LFA-1 (CD11a) mAb and 2C.LFA-1
2/2 T cells absorbed the
pMVs at a greatly reduced level (Figure 1A and B). In contrast,
CD28/B7-1 interaction appeared to play only a marginal role in
the absorption. The level of pMV absorption increased progres-
sively as the culture time extended (Figure 1B).
We examined 2C T cells cultured with the pMVs with confocal
microscopy (Supplementary Figure S2B). The absorbed pMVs
visualized as punctate B7-1 staining were easily found on the cell
surface when 2C T cells were cultured with the QL9 (or P2Ca)-
loaded pMVs.
Involvement of intracellular signaling in the pMV-
absorption
As LFA-1 expressed in resting naı ¨ve T cells exists mainly in
inactive low affinity state [6], results that LFA-1 played a key role
in the pMV-absorption suggested the transition of LFA-1 to active
high affinity state in the course of the pMV-absorption, which
could occur via ‘inside-out’ signaling induced by engagement of
2C TCRs with L
d/QL9 (or L
d/P2Ca) complexes [14].
We investigated the possible involvement of intracellular
signaling in the pMV-absorption by treating 2C T cells with
various pharmacological agents targeting specific signaling mole-
cules (Figure 1C).
Treatment of 2C T cells with PP2 and Wortmannin, inhibitors
of protein tyrosine kinases (PTKs) and phosphoinositide 3-kinase
(PI3-K), respectively, dramatically reduced the level of pMV-
absorption, while treatment with Pervanadate, a protein tyrosine
phosphatase inhibitor, significantly elevated the level of pMV-
absorption.
Treatment with Cytochalasin D (an inhibitor of actin
polymerization), BAPTA/AM (a membrane permeable intracel-
lular Ca
2+ chelator) and Forskolin (an activator of adenylyl cyclase)
also inhibited the pMV-absorption.
Treatment of 2C T cells with Cyclosporin A (an inhibitor of
Ca
2+-dependent serine/threonine phosphatase) and Nocodazole (a
tubulin antagonist) had little effect on the pMV absorption.
Together, these results revealed the importance of specific
intracellular signaling cascades in the pMV-absorption.
Induction of F-actin polymerization during culture of 2C
T cells with the pMVs
It is well known that TCR triggering promptly induces F-actin
polymerization via activation of signaling pathways involving
PTKs, PI3-K, Vav, Rac and Abi/Wave complex which are also
known to play a role in integrin activation [15,16,17].
Figure 1. Importance of intracellular signaling cascades in the
pMV-absorption. (A) Wild type (WT), CD28
2/2, and LFA-1
2/2 2C T
cells, pre- treated with the respective mAbs, were cultured with or
without the peptide-loaded L
dB7-1ICAM-1 pMVs, as indicated, followed
b ym A bs t a i n i n gf o rB 7 - 1a n df l o wc y t o m e t r i ca n a l y s i s .M e a n
fluorescence intensities (MFIs) of B7-1 staining relative to that of WT
2C T cells, pre-treated with control mAb and cultured with the QL9-
loaded pMVs, were plotted. Note that P1A peptide forms complex with
L
d but L
d/P1A complex is not recognized by 2C TCR [8]. (B)W T2 CT
cells, pre-treated with the respective mAbs, were cultured with the
peptide-loaded pMVs for different periods of time, as indicated, and
stained for B7-1. (C) WT 2C T cells were treated with PP2 (PP),
Wortmannin (WM), Pervanadate (PV), Cytochalasin D (CT), BAPTA/AM
(BA), Forskolin (FS), Cyclosporin A (CC) and Nocodazole (NZ),
respectively, as indicated, before culture with the QL9-loaded pMVs.
MFIs of the B7-1 staining relative to that of 2C T cells treated with DMSO
alone were plotted.
doi:10.1371/journal.pone.0006044.g001
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cells rapidly increased following culture with the pMVs loaded
with either QL9 or p2Ca peptide. The level of F-actin in those
cells reached a peak within 5 minutes of the culture and remained
elevated for at least 30 minutes (Figure 2A).
Treatment of wild-type 2C T cells with anti-LFA-1 and anti-
CD28 mAbs had little effect on the F-actin polymerization
(Figure 2B). In line, 2C.LFA-1
2/2 and 2C.CD28
2/2 T cells
cultured with the QL9-loaded pMVs showed comparable levels of
F-actin content as wild-type 2C T cells.
Consistent with results from the flow cytometric analysis,
microscopic analysis showed more prominent cortical F-actin
staining in 2C T cells cultured with the pMVs loaded with QL9
peptide than in control T cells and both anti-LFA-1 and anti-
CD28 mAb blocking exerted little effect on the level of cortical F-
actin (Figure 2C).
Reflecting critical roles of PTKs and PI3-K in early membrane-
proximal TCR signaling [18], PP2 and Wortmannin treatments
strongly inhibited the F-actin polymerization (Supplementary
Figure S3A). In addition, activation of PTKs and PI3-K,
exemplified by phosphorylation of phospholipase C-c1 (PLC-c1)
and Akt, respectively, were readily detected shortly after culture
with the QL9-loaded pMVs (Supplementary Figure S3B and C).
Together, these results illustrated that the sole interaction of 2C
TCR with cognate pMHC expressed in L
dB7-1ICAM-1 pMVs
could trigger signaling events involved in LFA-1 activation process
(Figure 3).
High throughput screening for systematic study on
molecular mechanisms underlying the pMV-absorption
The assay system for detecting the pMV-absorption has several
features suitable for the systematic investigation of molecular
mechanisms governing TCR-mediated LFA-1 activation. Firstly,
while the pMV-absorption proceeds via complex cellular and
molecular mechanisms (Figure 3), the assay itself is simple and
expeditious and thus can be easily implemented as a high
throughput assay (Figure 4A). Secondly, as primary T cells along
with physiological ligands expressed in biological membranes are
employed, results obtained from the experiments may have
superior physiological relevance. Thirdly, as flow cytometry,
which enables interrogation of individual cells with multiple
parameters, is employed in the assay, only a selected population of
cells in the samples, e.g., CD8
+ and live T cells, can be included in
data analysis and thus interpretation of assay results and
Figure 2. Analysis of F-actin polymerization occurring during
culture of 2C T cells with the pMVs. (A) Wild type (WT) 2C T cells
were cultured with the peptide-loaded pMVs for different periods of
time and stained for F-actin with FITC-labeled phalloidin followed by
flow cytometric analysis. Fold changes in the level of F-actin relative to
that of 2C T cells fixed immediately after mixing with the QL9-loaded
L
dB7-1ICAM-1 pMVs were plotted. Histograms represent the F-actin
staining of 2C T cells cultured with P1A- (solid grey), P2Ca- (dotted
black) and QL9- (solid black) loaded pMVs for 5 min, respectively. (B)
WT, CD28
2/2 and LFA-1
2/2 2C T cells were treated with the respective
mAbs, as indicated, before 5 min culture with the QL9-loaded pMVs.
Fold changes in the level of F-actin during the culture were plotted. (C)
WT 2C T cells were pre-treated with the respective mAbs and cultured
with the peptide-loaded pMVs, as indicated, for 20 min on poly-L-
lysine-coated coverslips followed by staining for F-actin with FITC-
labeled phalloidin.
doi:10.1371/journal.pone.0006044.g002
Figure 3. Schematic representation of the mechanistic model
for 2C T cell absorption of the pMVs. The whole process of the
pMV-absorption commences as 2C TCRs interact with cognate pMHCs
expressed on the pMVs. The TCR/pMHC interaction activates intracel-
lular signaling cascades (i.e., ‘‘inside-out’’ signaling) resulting in
promotion of LFA-1 function and thereby stabilization of T/pMV
contact. According to that model, the pMV-absorption can be inhibited
by three different routes: (i) interruption of TCR/pMHC interaction, (ii)
interruption of LFA-1/ICAM-1 interaction, (iii) inhibition of intracellular
signaling cascades for LFA-1 activation.
doi:10.1371/journal.pone.0006044.g003
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repeated washes, which are time-consuming and likely generate
experimental errors but are often imperative in other types of
assays using a fluorescence-tagged material for reducing the level
of background, are not necessary, reliability of the assay becomes
high; due to fluidic operation of flow cytometry that takes and
carries cells with a stream of sheath buffer to the laser
interrogation point, residual free fluorescent reagents in the
samples does not hamper analysis of samples. Indeed, Z-factor
of the assay, a parameter widely used as a measure of variability
and reproducibility (i.e., intra-assay variation) of high throughput
assay, turned out highly desirable (Figure 4B). Inter-assay
variation, inferred by average and standard deviation (SD) of Z-
factors drawn from four separate sets of experiments, was also
found favorable; the average and SD were 0.72 and 0.046,
respectively.
In order to evaluate the practicality and effectiveness of the high
throughput assay, we attempted to screen a 2000-membered
chemical library (The Spectrum Collection
TM, MicroSource
Discovery, Inc.) composed of both natural and synthetic small
molecules whose biological functions have been identified to
different extents. We screened the library using 96 well format in
conjunction with an automatic sampler (BD High Throughput
Sampler, BD Bioscience) equipped to a flow cytometer (BD
FACSCalibur); compounds were initially tested at 40 mM. After
completion of the HTS campaign, compounds showing over 75%
inhibition of the pMV-absorption were selected and retested twice
in duplicate to confirm the activity.
In summary of the HTS campaign, total 53 hits were isolated in
the primary screening and 46 compounds showed the reproduc-
ible activity; a false positive rate and a reconfirmation rate of the
HTS were approximately 0.4% (7 compounds out of 2000
compounds) and 86% (46 compounds out of 53 compounds),
respectively (http://www.mbcfoundation.org/pdfs/Lipinski%20-
Keynote%20address.pdf).
Potencies (IC50) and toxicities of hits showing the reproducible
activity were examined testing them at titrated concentrations; to this
end, instead of being fixed in paraformaldehyde, 2C T cells were
resuspended in a propidium iodide (PI)-containing buffer at the end
of the assay and immediately analyzed by flow cytometry.
Figure 4. High throughput screening for systematic study on molecular mechanisms underlying the pMV-absorption. (A) Flow
diagram of the high throughput screening (HTS) for isolation of small molecules modulating the pMV-absorption. (B) Z-factor was calculated with
averages and standard deviations of 32 sets of assays; each set included assays with control mAb plus QL9-loaded pMVs used as the positive control,
anti-LFA-1 mAb plus QL9-loaded pMVs used as the negative control and with control mAb plus P1A-loaded pMVs. (C)I C 50s (or ED50) and
pharmacological uses of hits isolated from the pilot scale HTS were summarized.
doi:10.1371/journal.pone.0006044.g004
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cytotoxicity (based on PI exclusion) at IC50 were isolated as final hits.
Here, a few hits deserve to be highlighted (Figure 4C).
Inhibition of the pMV-absorption by Genistein [19], a protein
tyrosine kinase inhibitor, appears consistent with the inhibition by
PP2 (Figure 1C). Papaverine and Ethaverine share the same core
chemical structure (Supplementary Figure S4A) and are used as
vasodialators. Papaverine has an inhibitory activity for phospho-
diesterase; thus, Papaverine treatment may increase the cellular
concentration of cAMP [20]. Given that, inhibition of the pMV
absorption by Papaverine appears in line with the inhibition by
Forskolin which activates adenylyl cyclase resulting in increase in
concentration of cAMP [21] (Figure 1C). Inhibitions of the pMV-
absorption by Berberine chloride [22], Cearoin [23], 3,39-
Diindoylmethane [24], Glafenine [25] and Oxyphenbutazone
[26] are intriguing for their known anti-inflammatory activity.
Inhibition by ZPCK, a cysteinyl protease inhibitor [27], is also
worth mentioning for the role of protease in LFA-1 activation [28].
Promotion of the pMV-absorption by structurally-related
histamine receptor antagonists and antidepressants
Another hit worth noting is Brompheniramine maleate (BPM), a
clinically used H1 histamine receptor antagonist [29]. Different
from other hits, it was selected due to its agonistic activity on the
pMV-absorption. Namely, the BPM treatment significantly
augmented the level of pMV absorption by 2C T cells; EC50 of
BPM was determined at 35 mM. The highly reproducible activity
of BPM led us to examine other structurally- or functionally-
related molecules (Figure 5A for chemical structures and
Supplementary Figure S4B for their names and pharmacological
uses). In summary, molecules sharing analogous structural
moieties with BPM, i.e., diaryl and alkylated amine functionalities,
revealed the common agonistic activity. Notably, among the
molecules tested, clinically available antidepressants with stronger
serotonin reuptake inhibition activity [30] (i.e., Fluoxetine,
Sertraline, Paroxetine, Chlomipramine) showed the superior
activity (Figure 5B and C and Supplementary Figure S5).
Discussion
Encounter of T cells with APC carrying cognate pMHCs leads
to formation of TCR microclusters followed by generation of
immunological synapse (IS) at the interface of T/APC contact
[31]. While the formation of IS is vital for promoting firm and
stable T/APC contact and eliciting sustainable intracellular
signals, key intracellular signaling events for T cell activation are
elicited prior to IS formation, at the stage of TCR microcluster
formation. Considering the size of L
dB7-1ICAM-1 pMV and the
number of pMHCs expressed on the pMVs, the process of 2C T
cell absorption of the pMVs may mimic the early stage of T-APC
interaction leading to and immediately following the formation of
TCR microclustering.
Since LFA-1 is expressed in low-affinity/avidity form in resting
naı ¨ve T cells [6], the finding that LFA-1 played a pivotal role in
the pMV absorption by 2C T cells (Figure 1A) was intriguing and
suggested the involvement of ‘inside-out’ signaling evoked by TCR
stimulation. Involvement of intracellular signaling in pMV-
absorption was clearly illustrated by the experiments using
pharmacological reagents to inhibit the activity of specific
signaling molecules (Figure 1C).
Results that the interaction of 2C TCR with a cognate pMHC
on the pMVs was necessary and sufficient for the F-actin
polymerization are in agreement with the results of others
Figure 5. Structure-activity relationship study on the agonistic
activity of Brompheniramine on the pMV-absorption. (A)
Chemical structures of structurally- or functionally-related compounds
of Brompheniramine are shown. Refer to Supplementary Figure 4 for
their names and pharmacological uses. (B) 2C T cells were treated with
compounds shown in (A) at titrated concentrations and cultured with
the QL9-loaded pMVs followed by mAb staining for B7-1. MFIs of the
B7-1 staining relative to that of 2C T cells treated with DMSO alone were
plotted. Experiments were performed in duplicate and standard
deviations of duplicate samples were all within 10% of the averages.
Shown is one of three representative experiments. (C)E D 50s of the
compounds were calculated from the experiments described in (B) and
plotted against Kis of the compounds for 5-HT transporter. Note: Ki
values used in this plot were adopted from PDSP Ki data base (http://
pdsp.med.unc.edu/pdsp.php). To ensure data consistency, only the Ki
values obtained using rat frontal cortex as the source of 5-HT
transporter and [
3H]-5-HT as the hot ligand were used [45].
doi:10.1371/journal.pone.0006044.g005
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pMV-absorption was initiated upon TCR triggering.
In view of the above results, we propose a mechanistic model
that 2C T cell absorption of L
dB7-1ICAM-1 pMV is preceded by
the activation of LFA-1 (Figure 3). Prior to LFA-1 activation, the
interaction of 2C TCRs with the cognate pMHCs may be too
weak and transient to establish stable pMV absorption. Here,
strong binding may hinge crucially on prior TCR-dependent
‘inside-out’ signaling to activate LFA-1 function.
Applying the assay for detecting the pMV-absorption, we
established a HTS platform. Use of primary cells in study of
biological phenomena is considered ideal for gathering physiolog-
ically relevant results. Nevertheless, difficulty of securing large
number of primary cells often makes it impractical to use them in
large scale experiments such as HTS. We circumvented the
problem by employing TCR Tg mice; more than 2–3610
7
primary resting naı ¨ve T cells with single antigenic specificity can
be obtained from whole body lymph nodes of one mouse [32].
While purified recombinant ligands are routinely used in studies
of receptor/ligand interactions in both protein-based and cell-
based assays, the cost of ligand expression and purification is high
and the condition in which receptor-ligand interactions take place
is fairly non-physiological as the purified ligands are often
immobilized on the surface of plastic in those assays [33,34]. In
contrast, because the ligands used in our assay are prepared as
expressed in vesicluated plasma membranes, the ligand prepara-
tion cost is cheaper and receptor/ligand interactions take place in
a more physiological condition.
Even though flow cytometric analysis holds advantages of
superior sensitivity, statistical precision and concomitant exami-
nation of multiple parameters, it has been less popular in HTS due
to its limitation in throughput of sample analysis and lack of
automatic sampling devices. Those issues have been resolved
considerably in recent years by the invention of affordable
automatic high throughput samplers (BD Bioscience). Here, a
high throughput flow cytometry system developed by Dr. Sklar
and his colleagues deserves a special attention [35].
The pilot scale HTS validated the usefulness of our HTS
platform in the systematic investigation of molecular mechanisms
controlling TCR-mediated membrane-proximal signaling cas-
cades leading to LFA-1 activation. Besides hit compounds
mentioned in the Results section, it is also of note that several
mitochondrial antagonists, i.e., a group of rotenoids typified by
Rotenone and Deguelin [36] and Antimycin [37] (Figure 4), were
isolated as hits with very high potencies; IC50 values of the
rotenoids were in the range of 200–400 nM and that of Antimycin
was ,10 nm. While the molecular mechanism for the inhibition of
the pMV-absorption by those mitochondrial antagonists is yet to
be understood, it was suggested that the inhibition might be
related to AMP-activated kinase [38], whose activation was
ubiquitously observed following the mitochondrial antagonist
treatments (author’s unpublished data).
It is intriguing that structurally-related H1 histamine receptor
antagonists and antidepressants promoted 2C T cell absorption of
the pMVs. Here, it has to be mentioned that studies by others [39]
have shown activation of specific T cell signaling events after
Fluoxetin treatment; e.g., activation of protein kinase C, induction
of Ca
2+ entry. In addition, Zimelidine, the second generation
serotonin-specific reuptake inhibitor (SSRI), had been withdrawn
out of the market after finding that it could have caused severe side
effects of hypersensitivity reactions such as Guillain-Barre
syndrome, a life-threatening neurological autoimmune disease,
and flu-like syndromes [29]. Even though such side effects are not
widespread among other antidepressants, it has been a concern
that the structurally related antidepressants may cause similar
adversary effects as Zimelidine in certain conditions. Our results
support the notion that the structurally-related antidepressants
may modulate T cell activation process.
Materials and Methods
Ethics Statement
All procedures met the guidelines of the National Institutes of
Health ‘‘Guide for the Care and Use of Laboratory Animals’’.
Animals
C57BL/6J (B6), CD28
2/2 (B6) and CD18
2/2 (LFA-1
2/2) (B6)
mice were purchased from The Jackson Laboratory and
maintained at The Scripps Research Institute (TSRI). 2C TCR
transgenic mice [32] were bred at TSRI. 2C TCR Tg mice
deficient in CD28 (2C.CD28
2/2) and CD18 (2C.LFA-1
2/2)
expression were generated in our laboratory.
Cell lines and culture media
Dros APCs were maintained in Schneider’s medium supple-
mented with 10% fetal bovine serum (FBS) plus antibiotics as
described [8].
Peptides, chemicals and mAbs
QL9 (QLSPFPFDL), p2Ca (LSPFPFDL) and P1A
(LPYLGWLVF) peptides were purchased from Invitrogen.
PP2, Wortmannin, Cyclosporin A, Cytochalasin D, Nocoda-
zole, BAPTA/AM, and Forskolin were purchased from EMD
Bioscience. Pervanadate was prepared from Na-orthovanadate
(Sigma) as described [40].
Diphenhydramine, Ranitidine, Thioperamide, Fluoxetine, Ser-
traline, Fluvoxamine, Paroxetine, Clomipramine, Imipramine,
Desipramine, Doxepin, and GBR-12935 were purchased from
Sigma. Brompheniramine maleate was purchased from Micro-
Source Inc. Zimelidine was purchased from Tocris Bioscience.
Anti-CD28 (37.51) and anti-CD11a (M17/4) were purchased
from Biolegend. Rat mAb (RTK 2758) was purchased from
Biolegend and used as an isotype control mAb. FITC-conjugated
TCR-b (H57-597) mAb, PE-conjugated anti-B7-1 (16-10A1), anti-
L
d (24-14-8), anti-ICAM-1 (YN1/1.7.4) and anti-B7-2 (GL-1)
mAbs and Alexa 647-conjugated anti-CD8 (53-6.7) and anti-
CD18 (M18/2) mAbs were purchased from Biolegend. Alexa 546-
conjugated anti-B7-1 (16-10A1) mAb was prepared in our
laboratory using Alexa 546 labeling kit (Invitrogen). FITC-labeled
phalloidin was purchased from Sigma.
Polyclonal antibodies directed to pan-Akt, phospho-Akt
(Thr
308), PLC-c1 and phospho-PLC-c1 (Tyr
783) were purchased
from Cell Signaling Technology. Horseradish peroxidase-tagged
goat anti-rabbit IgG Ab was purchased from Santa Cruz
Biotechnology.
Preparation of pMVs
PMVs were prepared as described by Goldberg and Kornfeld
[41] with modifications. In brief, Dros APCs induced to express
transfected mouse immuno-molecules were washed and resus-
pended in buffer A (15 mM KCl, 1.5 mM MgCl2, 1 mM DTT,
10 mM Hepes, pH 7.5) containing cocktail of protease inhibitors
(Sigma) and lyzed with Contes homogenizer (loose-fitting pestle).
The cell lysate was spun down briefly at low centrifugal force
(15006 g) to remove unlyzed cells and nuclei. The supernatant
was recovered and mixed with one fifth volume of buffer B
(375 mM KCl, 22.5 mM MgCl2, 1 mM DTT, 220 mM Hepes,
pH 7.5) containing protease inhibitors and subjected to ultracen-
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membrane particles. The resulting pellet was resuspended in
buffer C (40 mM Tris?Cl, 10 mM KCl, 10 mM NaCl, 0.2 mM
EDTA, pH 7.2) and finely dispersed using Contes homogenizer
(tight-fitting pestle). The resuspended membrane vesicles were
further fractionated by sucrose gradient ultracentrifugation (step
gradients of 20, 35, 40 and 50%); 200,0006 g for 2 hrs at 0uC.
The membrane vesicles derived from plasma membrane fraction
were then taken from the interface of 20/35% sucrose layers,
aliquoted and stored at 280uC. The amount of pMVs was
determined by measuring the protein concentration in the sample.
Estimation of the average number of each ligand
expressed in the pMVs
The average number of each mouse ligand expressed in L
dB7-
1ICAM-1 pMVs was estimated, based on the number of each
ligand expressed in the intact Dros APCs and average surface
areas of the Dros APCs and the pMVs. The average number of
each ligand expressed in the intact Dros APCs was first estimated
using Quantum
TM Simply Cellular Kit and Quickcal software
(Bang Laboratories, Fisher, IN) following manufacturer’s manual.
The average number of each ligand expressed in the pMVs was
then calculated as follows; the average number of each ligand
expressed in the pMVs=(the average number of each ligand
expressed in the intact Dros APCs) 6 (average surface area of
pMVs)/(average surface area of intact Dros APCs). The average
diameter of Dros APCs is about 20 mm.
Purification of 2C TCR Tg T cells
2C T cells were negatively purified from pooled lymph nodes
using CD8a
+ T Cell Isolation MACS
TM kit (Miltenyi Biotech). If
needed, the MACS purified 2C T cells were further purified by
panning on anti-CD8 mAb (3.168)-coated plates to isolate CD8
+
2C T cells.
Assay for 2C T cell absorption of L
dB7-1ICAM-1 pMVs
Forty five microliters of purified 2C T cells (1610
6/ml) in a pre-
warmed culture medum (DMEM medium plus 10% FCS) were
mixed with 5 ml of the peptide-loaded pMVs (0.5 mg/ml) in round-
bottom 96 well plate and cultured for 30 min in a 37uC humidified
CO2 incubator. After culture, PE-conjugated anti-B7-1 plus Alexa
647-conjugated anti-CD8 mAbs were added and the plate was
incubated on ice for 20 min. The plate was then filled with ice-cold
FACS buffer (16PBS, 1% BSA, 2.5% horse serum, 2 mM EDTA)
and spun down for cell washing. The T cells were then fixed with
2% PFA overnight at 4uC before analysis by flow cytometry.
Alternatively, the T cells were resuspended in the FACS buffer
containing propidium iodide (PI) and immediately analyzed.
For compound testing, 2C T cells were incubated with 0.5 mlo f
compounds in DMSO for 30 min at 37uC prior to culture with the
pMVs.
Flow cytometric analysis of F-actin contents
F-actin contents in 2C T cells were measured as described [42].
Briefly, 100 ml of purified CD8
+ 2C T cells (2610
6/ml), pre-
warmed at 37uC for 15 min, was cultured with 10 ml of the
peptide-loaded pMVs (0.5 mg/ml). After culture, the T cells were
washed with ice-cold 16 PBS and fixed with 4% paraformalde-
hyde (PFA) for 1 hr at rt, permeabilized with 0.1% Tritin X-100
and stained with FITC-conjugated phalloidin plus Alexa 647-
conjugated anti-CD8 mAb for 20 min at rt. After thorough
washing with 16 PBS, the T cells were analyzed by flow
cytometry.
Confocal microscopy [43]
Purified CD8
+ 2C T cells (1610
5) were cultured with peptide-
loaded pMVs on poly-L-lysine-coated coverslips. After culture, 2C
T cells were fixed with 2.5% PFA for 30 min at rt, permeabilized
with 0.2% Saponin for 15 min at rt, treated with blocking buffer
(16 PBS, 1% bovine serum albumin, 2.5% horse serum, 0.02%
Saponin) for 1 hr at rt and stained with fluorescence-labeled mAbs
for 30 min at rt. After thorough washing with 16PBS, T cells on
the coverslip were mounted on a glass slide with ImmunO
Immuno-Fluore Mounting Medium (MP Biomedicals). The
mounted specimens were observed under an Axiovert S100
TU
TM inverted microscope (Zeiss) connected to a LaserSharp
TM
(Bio-Rad) confocal imaging system. The collected images were
analyzed using Image J software (National Institute of Health).
Western blot analysis
Purified 2C T cells cultured with peptide-loaded pMVs were
washed with ice-cold 16 PBS and lyzed in a cell lysis buffer
(50 mM Tris?HCl, 150 mM NaCl, 1% Igepal CA-630, pH 7.5)
containing cocktail of protease inhibitors (Sigma) followed by
sonication for further homogenization. The same amounts of
lysates (determined by the protein concentration) were separated
by SDS/PAGE and subjected to Western blotting as described
[44]. The proteins of interest were visualized by ECL reagent
(Pierce).
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